Evidence map›Paper›PMID 36373610›Full record

ReviewWomen's health (London, England)

Thyroid cancer in women of reproductive age: Key issues for the clinical team.

María Fernanda Toro-Wills, Angélica Imitola-Madero, Angelina Alvarez-Londoño, Abraham Hernández-Blanquisett, María Cristina Martínez-Ávila

Open access · goldAbstract readReview
In one paragraph

Review in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

María Fernanda Toro-WillsGynecology and Obstetrics Department, Centro Hospitalario Serena del Mar, Cartagena, Colombia.ORCID 0000-0003-0315-0007
Angélica Imitola-MaderoEndocrinology Division, Internal Medicine Department, Centro Hospitalario Serena del Mar, Cartagena, Colombia.
Angelina Alvarez-LondoñoRadiation Oncology, Cancer Institute, Centro Hospitalario Serena del Mar, Cartagena, Colombia.
Abraham Hernández-BlanquisettMedical Oncology, Cancer Institute, Centro Hospitalario Serena del Mar, Cartagena, Colombia.
María Cristina Martínez-ÁvilaMedical Oncology, Cancer Institute, Centro Hospitalario Serena del Mar, Cartagena, Colombia.ORCID 0000-0002-1542-0249

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women who are fertile experience a significant burden from thyroid cancer. In reality, delaying childbirth is the current trend in maternity. Women who have thyroid cancer may later want to get pregnant after it has been treated, which presents a multidisciplinary issue for their doctors. A variety of specialists are frequently involved in the treatment of thyroid cancer. This review aims to address the key elements of the strategy and places special emphasis on the significance of fertility in women with thyroid cancer diagnosis and remission. We will cover topics including the role of thyroid hormones in pregnancy and fertility.

Indexed as

ReproductionThyroid NeoplasmsFemaleFertilityHumansPregnancyfertilityphysiologyreproductionreproductive medicinethyroid cancer

Identifiers

PMID36373610
PMCPMC9666833
OpenAlexW4309365526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.